Alluri P, Newman, L. Basal-like and triple negative breast cancers: searching for positives among many negatives. (2014). Surgical Clinics of North American. 23(3): 567-577 doi:10.1016/j.soc.2014.03.003.
Badve S, Dabbs DJ, Schnitt SJ, Baehner TD, Decker T, Eusebi V, et al. (2011). Medscape Reference: Basal-like and Triple-negative Breast Cancers. Retrieved from: http://www.medscape.com/viewarticle/736911_6.
Morrow M, Burstein HJ, and Harris JR. Malignant tumors of the breast. DeVita VT Jr, Lawrence TS, & Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Edition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 79: 1117-1156.
National Cancer Institute. (2015, July 8). Breast Cancer Treatment for Health Professionals (PDQ®).
O'Reilly EA, et al. The fate of chemoresistance in triple negative breast cancer (TNBC). (2015). BBA Clinical. 3 (2015) 257–275.
Tomao F, Papa A, Zaccarelli E, et al. Triple-negative breast cancer: new perspectives for targeted therapies. (2015). OncoTargets and Therapy. 8:177-193.
Wahba HA, El-Hadaad HA. Current approaches in treatment of triple-negative breast cancer. (2015). Cancer Biology and Medicine. 12:106-116. doi: 10.7497/j.issn.2095-3941.2015.0030.×